Linaclotide
Back to searchMolecule Structure
Scientific Name
Linaclotide
Description of the Drug
Linaclotide is a guanylate cyclase-C agonist used to treat constipation associated with irritable bowel syndrome or that is idiopathic in nature.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08890
http://www.drugbank.ca/drugs/DB08890
Brand Name(s)
Constella, Linzess
Company Owner(s)
Allergan Sales Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Heat-stable enterotoxin receptor | SINGLE PROTEIN | AGONIST | CHEMBL1795197 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL13114620 | |
DrugBank | DB08890 | |
PubChem: Thomson Pharma | 17491264 | |
PubChem | 16158208 | |
Nikkaji | J3.220.720K | |
EPA CompTox Dashboard | DTXSID90234256 | |
DrugCentral | 4622 | |
rxnorm | LINZESS | LINACLOTIDE |
ChEBI | 68551 |